Shumei Lin

1.4k citations

39 papers · 506 indexed · h-index 14

Co-authors: Shulin Zhang Shihua Zhao Min Liu Yingli He Xueliang Yang Feng Ye Tianyan Chen Yunru Chen
Topics: Hepatitis B Virus Studies (23 papers)Liver Disease Diagnosis and Treatment (17 papers)Hepatitis C virus research (15 papers)
Cited by: Hepatology Epidemiology Geriatrics and Gerontology
Journals: Scientific Reports Chemical Engineering Journal Journal of Medicinal Chemistry
Partner nations: China Germany United States

In The Last Decade

Shumei Lin

39 papers receiving 498 citations

Peers

Countries citing papers authored by Shumei Lin

Since Specialization

Citations

This map shows the geographic impact of Shumei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shumei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shumei Lin more than expected).

Fields of papers citing papers by Shumei Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shumei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shumei Lin. The network helps show where Shumei Lin may publish in the future.

Co-authorship network of co-authors of Shumei Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shumei Lin. A scholar is included among the top collaborators of Shumei Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shumei Lin. Shumei Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Using machine learning to develop a five-item short form of the children’s depression inventory 2024 ·BMC Public Health ·Shumei Lin,Chengwei Wang,(unknown),Qian Zhang,Dan Luo,Jing Li,Junyi Li,Jiajun Xu	4
2	Loss of TP53 cooperates with c-MET overexpression to drive hepatocarcinogenesis 2023 ·Cell Death and Disease ·Yi Zhou,(unknown),Hongwei Xu,(unknown),(unknown),Zheng Zhang,Lihui Yang,Jingxiao Wang,(unknown),Diego F. Calvisi,Shumei Lin,Xin Chen,Haichuan Wang	16
3	Revisiting potential value of antitumor drugs in the treatment of COVID-19 2022 ·Cell & Bioscience ·Wenfang Zheng,(unknown),Shumei Lin,Peng Hou	2
4	Anemone chinensis Bunge aqueous enema alleviates dextran sulfate sodium-induced colitis via inhibition of inflammation and regulation of the colonic mucosal microbiota 2022 ·Journal of Ethnopharmacology ·Lina Dong,(unknown),Qian Li,Jiankuan Li,Guangxin Chen,(unknown),Yafeng Li,Liping Zhao,(unknown),Xiaoyan Wang,Xiaojing Liu,(unknown),Shumei Lin	9
5	The decline of HBV RNA associated with HBeAg seroconversion and double-negative HBV DNA and RNA in chronic hepatitis B patients who received entecavir therapy: a 10-year retrospective cohort study 2022 ·Annals of Translational Medicine ·Feng Ye,Wenjuan Zhao,Xueliang Yang,(unknown),(unknown),(unknown),Yunru Chen,Xiaojing Liu,Jun Li,Kang Li,Jie Zheng,Shumei Lin,Lei Shi	2
6	Baseline quantitative HBcAb strongly predicts undetectable HBV DNA and RNA in chronic hepatitis B patients treated with entecavir for 10 years 2021 ·Scientific Reports ·Xi Zhang,(unknown),Lei Shi,Xueliang Yang,Yunru Chen,Xiaojing Liu,Jun Li,Feng Ye,Shumei Lin	3
7	Mammalian Target of Rapamycin Complex 2 Signaling Is Required for Liver Regeneration in a Cholestatic Liver Injury Murine Model 2020 ·American Journal Of Pathology ·Yi Zhou,Meng Xu,Liu Pin,Bin-yong Liang,Manning Qian,Haichuan Wang,Xinhua Song,Pranavanand Nyshadham,Li Che,Diego F. Calvisi,Feng Li,Shumei Lin,Xin Chen	9
8	Investigation of hepatitis B virus (HBV) rtS78T/sC69* mutation in a large cohort of chronic HBV-infected patients with nucleoside/nucleotide analogue treatment 2019 ·Antiviral Research ·(unknown),Yan Liu,Rongjuan Chen,Ming Niu,Lujie Liu,Xiaodong Li,Qi Li,Bixia Huang,Jun Wang,Dongping Xu,Shumei Lin	5
9	Acoustic Structure Quantification Versus Point Shear Wave Speed Measurement for the Assessment of Liver Fibrosis in Viral Hepatitis B 2018 ·Ultrasound in Medicine & Biology ·(unknown),(unknown),Hong Ai,(unknown),(unknown),(unknown),(unknown),Shumei Lin	6
10	Relationship between the mechanism of hepatitis B virus father–infant transmission and pregnancy outcome 2016 ·Archives of Gynecology and Obstetrics ·(unknown),Yi Liu,Xiaojing Liu,Na Li,(unknown),(unknown),(unknown),Feng Ye,Shumei Lin	16
11	Effects of recombinant human adenovirus-p53 on the regression of hepatic fibrosis 2016 ·International Journal of Molecular Medicine ·(unknown),(unknown),(unknown),Shumei Lin,Min Liu	6
12	Synthesized peptide 710–725 from HCV subtype 1a E2 glycoprotein blocks HCV infection through competitive binding of CD81 2016 ·International Journal of Molecular Medicine ·Xiaojing Liu,(unknown),Shumei Lin,Min Liu	7
13	Kushenin induces the apoptosis of HCV-infected cells by blocking the PI3K-Akt-mTOR pathway via inhibiting NS5A 2016 ·Experimental Cell Research ·Yi Zhou,(unknown),Xiaojing Liu,Shumei Lin,(unknown),Min Liu	2
14	Plasma exchange-centered artificial liver support system in hepatitis B virus-related acute-on-chronic liver failure: a nationwide prospective multicenter study in China 2016 ·Hepatobiliary & pancreatic diseases international ·Jiajia Chen,Jianrong Huang,Qian Yang,Xiaowei Xu,Xiaoli Liu,Shaorui Hao,Huifen Wang,Tao Han,Jing Zhang,Jianhe Gan,Zhiliang Gao,Yuming Wang,Shumei Lin,Qing Xie,Chen Pan,Lanjuan Li	50
15	Synthesized peptides 705–734 from hepatitis C virus E2 glycoprotein induce dendritic cell maturation by activating p38 MAPK signaling 2015 ·International Immunopharmacology ·Xiaojing Liu,(unknown),Shumei Lin,Min Liu	5
16	The balance between intrahepatic IL-17+ T cells and Foxp3+ regulatory T cells plays an important role in HBV-related end-stage liver disease 2011 ·BMC Immunology ·(unknown),Hongli Liu,(unknown),(unknown),Tianyan Chen,(unknown),Shulin Zhang,Shumei Lin,Yingren Zhao	41
17	An early decrease in serum HBeAg titre is a strong predictor of virological response to entecavir in HBeAg‐positive patients 2011 ·Journal of Viral Hepatitis ·(unknown),Shumei Lin,(unknown),Tianyan Chen,Min Liu,Yi Chen,(unknown),(unknown),Shuyu Zhang	19
18	Hepatitis B virus infection and replication in primary cultured human granulosa cells 2010 ·Archives of Virology ·Yan Jin,(unknown),Juanzi Shi,(unknown),Shihua Zhao,Shumei Lin,Tianyan Chen,Min Liu,Yingli He,Shulin Zhang	13
19	Host susceptibility to persistent hepatitis B virus infection 2006 ·World Journal of Gastroenterology ·Yingli He,Shihua Zhao,Shulin Zhang,Shumei Lin	42
20	Screening and identification of interacting proteins with hepatitis B virus core protein in leukocytes and cloning of new gene C1 2006 ·World Journal of Gastroenterology ·Shumei Lin	5

About Shumei Lin

Shumei Lin is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 39 papers that have together received 506 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (23 papers), Liver Disease Diagnosis and Treatment (17 papers) and Hepatitis C virus research (15 papers). The work is most often cited by research in Hepatology (270 citations), Epidemiology (308 citations) and Geriatrics and Gerontology (16 citations). Shumei Lin has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Shulin Zhang, Shihua Zhao, Min Liu, Yingli He, Xueliang Yang, Feng Ye, Tianyan Chen, Yunru Chen, Yingren Zhao and Hongli Liu. Their work appears in journals such as Scientific Reports, Chemical Engineering Journal and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact